Soft-Tissue Sarcomas in Adults in Ecuador in the Period 2010-2020.

Q2 Medicine

Sarcoma Pub Date : 2022-01-01 DOI:10.1155/2022/1391537

Xavier Sánchez, Andrés Moreno Roca, Ruth Jimbo-Sotomayor, Luciana Armijos Acurio, Alfredo Viloria Cestari

{"title":"Soft-Tissue Sarcomas in Adults in Ecuador in the Period 2010-2020.","authors":"Xavier Sánchez, Andrés Moreno Roca, Ruth Jimbo-Sotomayor, Luciana Armijos Acurio, Alfredo Viloria Cestari","doi":"10.1155/2022/1391537","DOIUrl":null,"url":null,"abstract":"Background: Soft-tissue sarcomas (STSs) are rare tumors; they represent 1% of all tumors in adults. There are new diagnostic techniques to differentiate tumor types, and surgery continues to be the most important treatment for STS.Methods: This cross-sectional study analyzed the morbidity and mortality caused by STS in adults between 2010 and 2020 using national databases.Results: A total of 8,393 patients hospitalized due to STS were reported. The total number of deaths in Ecuador due to STS was 7,088 over the last decade, the provinces of Pichincha and Guayas registered the highest number of cases, and the mortality rate was 1.2 to 2.0 per 100,000 people. It is noteworthy that the lowest point of registered cases was in 2012.Conclusion: Soft-tissue sarcomas are rare tumors in Ecuador. The morbidity and mortality caused by these tumors have not changed in the last decade. National studies are needed to determine the prevalence of this illness and study intervention to lower mortality.","PeriodicalId":21431,"journal":{"name":"Sarcoma","volume":"2022 ","pages":"1391537"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807296/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sarcoma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/1391537","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Soft-tissue sarcomas (STSs) are rare tumors; they represent 1% of all tumors in adults. There are new diagnostic techniques to differentiate tumor types, and surgery continues to be the most important treatment for STS.

Methods: This cross-sectional study analyzed the morbidity and mortality caused by STS in adults between 2010 and 2020 using national databases.

Results: A total of 8,393 patients hospitalized due to STS were reported. The total number of deaths in Ecuador due to STS was 7,088 over the last decade, the provinces of Pichincha and Guayas registered the highest number of cases, and the mortality rate was 1.2 to 2.0 per 100,000 people. It is noteworthy that the lowest point of registered cases was in 2012.

Conclusion: Soft-tissue sarcomas are rare tumors in Ecuador. The morbidity and mortality caused by these tumors have not changed in the last decade. National studies are needed to determine the prevalence of this illness and study intervention to lower mortality.

Abstract Image

查看原文本刊更多论文

2010-2020年厄瓜多尔成人软组织肉瘤

背景:软组织肉瘤是一种罕见的肿瘤;它们占所有成人肿瘤的1%。有新的诊断技术来区分肿瘤类型，手术仍然是STS最重要的治疗方法。方法:本横断面研究使用国家数据库，分析2010年至2020年成人STS的发病率和死亡率。结果:共报告8,393例STS住院患者。在过去十年中，厄瓜多尔因性传播疾病死亡的总人数为7 088人，皮钦查省和瓜亚斯省登记的病例最多，死亡率为每10万人1.2至2.0人。值得注意的是，登记病例的最低点是在2012年。结论:软组织肉瘤在厄瓜多尔是罕见的肿瘤。这些肿瘤引起的发病率和死亡率在过去十年中没有改变。需要进行全国性的研究来确定这种疾病的患病率，并研究降低死亡率的干预措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Sarcoma Medicine-Radiology, Nuclear Medicine and Imaging

CiteScore

5.00

自引率

0.00%

发文量

审稿时长

14 weeks

期刊介绍： Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi"s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients.